A
Advanced Sleep Research | Berlin, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ACT-541468
Eloralintide
Orforglipron
Tirzepatide
LY3841136
LY3298176
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
Study GZRA is a master protocol that will support 2 independent studies, GZ01 and GZ02. Participants will be assigned to the appropriate study prior...
Active, not recruiting
Overweight or Obesity
OSA
Drug: Placebo
Drug: Orforglipron
Recently updated
The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and...
Begins enrollment this month
Overweight
Sleep Apnea, Obstructive
Drug: Placebo
Drug: Eloralintide
Trial sponsors
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems